Literature DB >> 30039737

Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Hanuma Kumar Karnati1, Joseph H Garcia1, David Tweedie1, Robert E Becker1,2, Dimitrios Kapogiannis3, Nigel H Greig1.   

Abstract

Traumatic brain injury (TBI) is a major cause of injury-related death throughout the world and lacks effective treatment. Surviving TBI patients often develop neuropsychiatric symptoms, and the molecular mechanisms underlying the neuronal damage and recovery following TBI are not well understood. Extracellular vesicles (EVs) are membranous nanoparticles that are divided into exosomes (originating in the endosomal/multi-vesicular body [MVB] system) and microvesicles (larger EVs produced through budding of the plasma membrane). Both types of EVs are generated by all cells and are secreted into the extracellular environment, and participate in cell-to-cell communication and protein and RNA delivery. EVs enriched for neuronal origin can be harvested from peripheral blood samples and their contents quantitatively examined as a window to follow potential changes occurring in brain. Recent studies suggest that the levels of exosomal proteins and microRNAs (miRNAs) may represent novel biomarkers to support the clinical diagnosis and potential response to treatment for neurological disorders. In this review, we focus on the biogenesis of EVs, their molecular composition, and recent advances in research of their contents as potential diagnostic tools for TBI.

Entities:  

Keywords:  extracellular vesicles (exosomes) and biomarkers; traumatic brain injury (TBI)

Year:  2018        PMID: 30039737      PMCID: PMC6444902          DOI: 10.1089/neu.2018.5898

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  154 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  High serum S100B levels for trauma patients without head injuries.

Authors:  B Romner; T Ingebrigtsen
Journal:  Neurosurgery       Date:  2001-12       Impact factor: 4.654

3.  High serum S100B levels for trauma patients without head injuries.

Authors:  R D Rothoerl; C Woertgen
Journal:  Neurosurgery       Date:  2001-12       Impact factor: 4.654

Review 4.  Inflammatory response in acute traumatic brain injury: a double-edged sword.

Authors:  Maria Cristina Morganti-Kossmann; Mario Rancan; Philip F Stahel; Thomas Kossmann
Journal:  Curr Opin Crit Care       Date:  2002-04       Impact factor: 3.687

Review 5.  Exosomes: composition, biogenesis and function.

Authors:  Clotilde Théry; Laurence Zitvogel; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

Review 6.  Diagnostic criteria and differential diagnosis of mild traumatic brain injury.

Authors:  J R De Kruijk; A Twijnstra; P Leffers
Journal:  Brain Inj       Date:  2001-02       Impact factor: 2.311

7.  Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

Authors:  B R Pike; J Flint; S Dutta; E Johnson; K K Wang; R L Hayes
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

8.  High serum S100B levels for trauma patients without head injuries.

Authors:  R E Anderson; L O Hansson; O Nilsson; R Dijlai-Merzoug; G Settergren
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

9.  Shed membrane fragment-associated markers for endometrial and ovarian cancers.

Authors:  Douglas D Taylor; Karen S Lyons; Ciçek Gerçel-Taylor
Journal:  Gynecol Oncol       Date:  2002-03       Impact factor: 5.482

10.  Serum S100B concentrations are increased after closed head injury in children: a preliminary study.

Authors:  Rachel Pardes Berger; Mary Clyde Pierce; Stephen R Wisniewski; P David Adelson; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2002-11       Impact factor: 5.269

View more
  17 in total

1.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

2.  Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.

Authors:  Miaad Bader; Yazhou Li; Daniela Lecca; Vardit Rubovitch; David Tweedie; Elliot Glotfelty; Lital Rachmany; Hee Kyung Kim; Ho-Il Choi; Barry J Hoffer; Chaim G Pick; Nigel H Greig; Dong Seok Kim
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

3.  Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury.

Authors:  Xiao Xiao; Peng Bai; Shuqiang Cao; Youjing Jiang; Weibo Liang; Tao Wang; Xiaolei Luo; Qiaozhi Guan; Linbo Gao; Lin Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

4.  Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.

Authors:  Lynn Pulliam; Bing Sun; Maja Mustapic; Sahil Chawla; Dimitrios Kapogiannis
Journal:  J Neurovirol       Date:  2019-01-04       Impact factor: 2.643

5.  A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic methamphetamine use disorder.

Authors:  Subhash Chand; Austin Gowen; Mason Savine; Dalia Moore; Alexander Clark; Wendy Huynh; Niming Wu; Katherine Odegaard; Lucas Weyrich; Rick A Bevins; Howard S Fox; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  J Extracell Vesicles       Date:  2021-12

Review 6.  Promise of extracellular vesicles for diagnosis and treatment of epilepsy.

Authors:  Dinesh Upadhya; Ashok K Shetty
Journal:  Epilepsy Behav       Date:  2019-10-18       Impact factor: 3.337

Review 7.  Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury.

Authors:  Kryshawna Beard; David F Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2020-06-02       Impact factor: 4.869

8.  Lipidomic characterization of extracellular vesicles in human serum.

Authors:  Suming Chen; Amrita Datta-Chaudhuri; Pragney Deme; Alex Dickens; Raha Dastgheyb; Pavan Bhargava; Honghao Bi; Norman J Haughey
Journal:  J Circ Biomark       Date:  2019-09-30

9.  (-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.

Authors:  Nigel H Greig; Daniela Lecca; Shih-Chang Hsueh; Carlos Nogueras-Ortiz; Dimitrios Kapogiannis; David Tweedie; Elliot J Glotfelty; Robert E Becker; Yung-Hsiao Chiang; Barry J Hoffer
Journal:  CNS Neurosci Ther       Date:  2019-12-11       Impact factor: 5.243

Review 10.  Exosomal Chaperones and miRNAs in Gliomagenesis: State-of-Art and Theranostics Perspectives.

Authors:  Celeste Caruso Bavisotto; Francesca Graziano; Francesca Rappa; Antonella Marino Gammazza; Mariantonia Logozzi; Stefano Fais; Rosario Maugeri; Fabio Bucchieri; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello; Domenico G Iacopino; Claudia Campanella
Journal:  Int J Mol Sci       Date:  2018-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.